Back to Journals » OncoTargets and Therapy » Volume 14

Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC

Total article views   HTML views PDF downloads Totals
6,062 Dovepress* 5,300+ 595 5,895
PubMed Central* 762 144 906
Totals 6,062 739 6,801
*Since 25 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 1 3 5

View citations on PubMed Central and Google Scholar